Kenyan Health Patient Information Leaflet
Therapeutic agent (verify pharmacological class)
Inflammatory eye conditions with possible or presence of bacterial infections Clinical selection for Fluoromethalone/ Neomycin eye drops should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Therapeutic agent (verify pharmacological class). Confirm site-specific dose, duration and monitoring before prescribing.
1- 2 drops QID to BD . During the first 24 to 48 hours, the dose may be safely increased to 1 drop every hour
Adverse reactions vary by agent. Counsel on common predictable effects and serious warning symptoms (allergy, severe rash, jaundice, unusual bleeding, severe GI symptoms, neurological changes). Report suspected ADRs via national pharmacovigilance channels.
Store as labelled. Keep out of reach of children.